B. Ahren et al., EFFECTS OF CHOLECYSTOKININ AND GLUCAGON-LIKE PEPTIDE-1 ON THE SECRETION OF PANCREATIC-POLYPEPTIDE IN MICE, Regulatory peptides, 59(3), 1995, pp. 297-302
The gut hormones, cholecystokinin (CCK) and truncated glucagon-like pe
ptide 1 (GLP-1(7-36)amide or GLP-1) both stimulate insulin secretion a
nd affect glucagon secretion in mice, but their effects on the secreti
on of other islet hormones have not been established in rodents. In th
e present study, we have examined the influence of the C-terminal octa
peptide of CCK, CCK-8, and GLP-1 on the secretion of pancreatic polype
ptide (PP) in the mouse by the use of a radioimmunoassay for rodent PP
. Mice were injected intravenously with CCK-8 (doses in the range of 0
.053-5.3 nmol/kg) or with GLP-1 (doses in the range of 1-32 nmol/kg) a
nd blood was sampled at 2, 6 or 10 min after the injection. Controls w
ere injected with saline. It was found that CCK-8 at 5.3 nmol/kg incre
ases plasma levels of both PP and insulin when the sample was taken at
2 min, but not at 6 or 10 min, after injection. These effects were bl
ocked by the selective CCKA-receptor antagonist, L-364,718 (2.4 mu mol
/kg). GPL-1 increased plasma insulin levels at 32 nmol/kg at 2 and 6 m
in after the injection, but plasma PP levels were unaltered. In conclu
sion, this study, using a newly developed radioimmunoassay for PP in r
odents, shows that CCK-8 but not GPL-1 stimulates PP secretion in mice
at dose levels where both peptides stimulate insulin secretion. Furth
ermore, PP secretion in response to CCK-8 showed a similarity with tha
t of insulin in terms of dose- and time-response characteristics as we
ll as sensitivity to CCKA-receptor antagonism.